Benzalkonium Chloride Antimicrobial Handwash Kills 98% Of Staph - ILTC
This article was originally published in The Tan Sheet
Executive Summary
Inclusion of benzalkonium chloride as a Category I ingredient in the tentative final monograph for OTC topical antimicrobial drug products is requested by International Laboratory Technology Corp. in a citizen petition submitted to FDA April 6.
You may also be interested in...
Benzalkonium chloride
FDA should not clear the ingredient for chronic use in health care antiseptic drug products due to a lack of data demonstrating long-term safety, Lonza's counsel says in an Aug. 3 letter. Responding to a citizen petition filed by International Laboratory Technology Corp. requesting GRAS/E status for the ingredient in OTC topical antimicrobial products, Lonza notes the agency has required data on chronic toxicity for a number of ingredients evaluated in the health care antiseptic drug products monograph, but the studies submitted by ILTC do not address long-term use. FDA currently considers benzalkonium chloride (.11%-.13%) a Category III ingredient - data insufficient to demonstrate safety/efficacy - except for short-term use (1"The Tan Sheet" April 24, p. 9)
Benzalkonium chloride
FDA should not clear the ingredient for chronic use in health care antiseptic drug products due to a lack of data demonstrating long-term safety, Lonza's counsel says in an Aug. 3 letter. Responding to a citizen petition filed by International Laboratory Technology Corp. requesting GRAS/E status for the ingredient in OTC topical antimicrobial products, Lonza notes the agency has required data on chronic toxicity for a number of ingredients evaluated in the health care antiseptic drug products monograph, but the studies submitted by ILTC do not address long-term use. FDA currently considers benzalkonium chloride (.11%-.13%) a Category III ingredient - data insufficient to demonstrate safety/efficacy - except for short-term use (1"The Tan Sheet" April 24, p. 9)
Topical Antimicrobial Test Standards Created By Third Party Possible - FDA
FDA is willing to consider working with third-party standard-setting organizations to develop testing methodologies for the healthcare antiseptic products final monograph.